Medical Consensus

Medical Consensus

Biosimilars, multiple sclerosis

Consensus process. Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations (Mult Scler. 2022 Dec;28(14):2177-2189.). Coordination of the consensus group, contribution to the systematic literature review and the revision of the...
Vitamin D and multiple sclerosis

Vitamin D and multiple sclerosis

multiple sclerosis

A comprehensive review. This review was written in collaboration with Mark Rametta (Bayer, USA) and Anthony Reder (University of Chicago, USA), and published in Neurology and Therapy (Neurol Ther. 2018;7(1):59–85). The article was among the five most popular articles...
Interferon beta 1b

Interferon beta 1b

multiple sclerosis

Interferon beta 1b following natalizumab discontinuation. One year, randomized, prospective, pilot trial (Gobbi C, Meier DS, Cotton F, Sintzel MB, et al. BMC Neurol. 2013;13:101). Support of the team at the Civico Hospital in Lugano, Switzerland, to design and...